Tablets 1 mg
Trade name: Anastrozole.
International nonproprietary name: Anastrozole.
Description: white or off- white round, biconvex, film- coated tablets. Coating roughness on tablets surface is permissible.
Composition: each tablet contains:
Active substance – anastrozole – 1 mg.
Excipients – sodium starch glycolate (A type), povidone K-25, calcium stearate, sodium lauryl sulfate, lactose monohydrate, opadry ll white (85 F).
Composition of coating substance (opadry ll white (85 F): partially hydrolyzed polyvinyl alcohol, macrogol/ polyethyleneglycol, talc (E553b); titanium dioxide (E171).
Pharmaceutical form: film – coated tablets.
Pharmacotherapeutic group: antineoplastic agent, estrogen synthesis inhibitor.
ATC code: L02BG03.
Indications for use:
Adjuvant therapy of early hormone- positive breast cancer in postmenopausal period.
Advanced breast cancer in postmenopausal women.
Adjuvant therapy of early hormone – positive breast cancer in postmenopausal period after taking tamoxifen during 2-3 years.
